Carolyn Quon, PharmD
Vice President, Global Medical Information Strategic Operations & Digital Solutions
专长:
Carolyn has nearly two decades of medical information call center, project management and client onboarding experience. Her focus continues to be on Medical Communications with a demonstrated track record of working successfully to support numerous clients in the pharmaceutical industry. Carolyn is skilled in U.S. Food and Drug Administration regulations, Medical Information Systems, performance metrics and KPIs, customer service, quality programs and call center development and administration.
Carolyn earned a PharmD from the University of Southern California, School of Pharmacy, and completed a specialized pharmacy residency for drug information at Stanford University. She holds a bachelor’s degree in biochemistry from the University of California San Diego.
Articles by Carolyn Quon, PharmD
Considerations for Globalization of Medical Information Services: A Service Partner Perspective
This poster details the considerations for globalizing medical information (MI) services. Traditionally, pharmaceutical companies began in one geographical region before expanding, but evolving regulations and research priorities for rare diseases, oncology/hematology, immunology, and cell and gene therapy have led to simultaneous global regulatory filings. To streamline operations and maintain control, these companies partner with global […]
Patient-centric Approach to Clinical Trial Support Leveraging Medical Information Services
The number of clinical studies conducted has steadily shown a significant increase year over year for the past two decades. However, the number of new drug and biologic approvals have not seen this same kind of increase. This causes several challenges for manufacturers such as increased competition and difficulty recruiting patients, particularly for rare diseases, […]
Compliance – The Competitive Differentiator to Commercialization: An Integrated Model Setting the New Global Standard
The Compliance experts at EVERSANA prove how integrated life science compliance has earned its seat at the table by demonstrating the value of increasing data-driven and technology-infused competitiveness in the successful commercialization of a new-age biopharma product.